| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for treatment of atopic eczema (atopic dermatitis) Part I | Journal of the European Academy of Dermatology and Venereology | 2012 | 495 |
| 2 | ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients | Journal of the European Academy of Dermatology and Venereology | 2016 | 329 |
| 3 | Guidelines for treatment of atopic eczema (atopic dermatitis) Part II | Journal of the European Academy of Dermatology and Venereology | 2012 | 316 |
| 4 | Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin | British Journal of Dermatology | 2009 | 303 |
| 5 | The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling | Nature Immunology | 2008 | 297 |
| 6 | ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis | Journal of the European Academy of Dermatology and Venereology | 2010 | 264 |
| 7 | Effect of sensory stimulation (acupuncture) on sympathetic and parasympathetic activities in healthy subjects | Journal of the Autonomic Nervous System | 2000 | 261 |
| 8 | Prevalence of Joint Disease in Patients with Psoriasis | American Journal of Clinical Dermatology | 2003 | 240 |
| 9 | Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis | British Journal of Dermatology | 2018 | 239 |
| 10 | Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris | British Journal of Dermatology | 2011 | 228 |
| 11 | ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children | Journal of the European Academy of Dermatology and Venereology | 2020 | 220 |
| 12 | Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe | Allergy: European Journal of Allergy and Clinical Immunology | 2011 | 201 |
| 13 | Quality of Life and Prevalence of Arthritis Reported by 5,795 Members of the Nordic Psoriasis Associations | Acta Dermato-Venereologica | 2002 | 186 |
| 14 | Old and New Biological Therapies for Psoriasis | International Journal of Molecular Sciences | 2017 | 179 |
| 15 | Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women | International Journal of Cancer | 2010 | 175 |
| 16 | When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council | Journal of the American Academy of Dermatology | 2017 | 170 |
| 17 | Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort | Journal of the European Academy of Dermatology and Venereology | 2015 | 164 |
| 18 | Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) | Journal of the European Academy of Dermatology and Venereology | 2020 | 159 |
| 19 | Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a Danish real‐world cohort study | Journal of Internal Medicine | 2013 | 155 |
| 20 | Quality of life in 6497 Nordic patients with psoriasis | British Journal of Dermatology | 2002 | 143 |
| 21 | Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study | British Journal of Cancer | 2008 | 143 |
| 22 | Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema | Contact Dermatitis | 2011 | 142 |
| 23 | Atopic dermatitis and birth factors: historical follow up by record linkage | BMJ: British Medical Journal | 1997 | 136 |
| 24 | Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 2 | Journal of Immunology | 2006 | 130 |
| 25 | Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis | American Journal of Clinical Dermatology | 2019 | 130 |
| 26 | Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2) | Journal of Dermatological Science | 2019 | 121 |
| 27 | Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa | British Journal of Dermatology | 2011 | 113 |
| 28 | Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover | Seminars in Immunopathology | 2017 | 110 |
| 29 | Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) | Journal of the American Academy of Dermatology | 2017 | 104 |
| 30 | Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks | British Journal of Dermatology | 2020 | 103 |
| 31 | The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group | British Journal of Dermatology | 2020 | 102 |
| 32 | European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis | Journal of the European Academy of Dermatology and Venereology | 2020 | 99 |
| 33 | IκBζ is a key driver in the development of psoriasis | Proceedings of the National Academy of Sciences of the United States of America | 2015 | 95 |
| 34 | The European treatment of severe atopic eczema in children taskforce (TREAT) survey | British Journal of Dermatology | 2013 | 94 |
| 35 | Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis | American Journal of Medicine | 2015 | 94 |
| 36 | Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma | Blood | 2019 | 94 |
| 37 | Self‐reported stress reactivity and psoriasis‐related stress of Nordic psoriasis sufferers | Journal of the European Academy of Dermatology and Venereology | 2004 | 88 |
| 38 | Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3‐Ser727 phosphorylation as a modulator of transcriptional activity | Experimental Dermatology | 2013 | 86 |
| 39 | Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma | Blood | 2016 | 86 |
| 40 | European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period | Journal of the European Academy of Dermatology and Venereology | 2019 | 85 |
| 41 | The Activity of Caspase-1 Is Increased in Lesional Psoriatic Epidermis | Journal of Investigative Dermatology | 2007 | 80 |
| 42 | Fractional CO2 laser resurfacing for atrophic acne scars: A randomized controlled trial with blinded response evaluation | Lasers in Surgery and Medicine | 2012 | 80 |
| 43 | High strength and high electrical conductivity Cu–Cr system alloys manufactured by hot rolling–quenching process and thermomechanical treatments | Materials Science & Engineering A: Structural Materials: Properties, Microstructure and Processing | 2012 | 80 |
| 44 | Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case–control study | British Journal of Cancer | 2009 | 79 |
| 45 | Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials | Annals of the Rheumatic Diseases | 2021 | 79 |
| 46 | STAT1 expression and activation is increased in lesional psoriatic skin | British Journal of Dermatology | 2013 | 78 |
| 47 | Single-cell heterogeneity in Sézary syndrome | Blood Advances | 2018 | 78 |
| 48 | Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis | American Journal of Clinical Dermatology | 2020 | 78 |
| 49 | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma | Oncotarget | 2015 | 78 |
| 50 | Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin | Archives of Dermatological Research | 1997 | 77 |
